gimli
AMBALALSA stock analysis context
AMBALAL SARABHAI ENT L Stock Context for AI Screening
AMBALAL SARABHAI ENT L is a small-cap stock in Healthcare. This page summarizes key screening signals for AMBALAL SARABHAI ENT L, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Open interactive AMBALALSA stock pagePrice
₹35.77
1W return
+10.13%
1M return
+12.66%
3M return
n/a
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
61.67
Turnover
₹0.57 cr
Why it can matter in screens
- Momentum: AMBALALSA is trend mixed or unavailable; RSI is 61.67.
- Returns: 1D -4.10%, 1W +10.13%, 1M +12.66%, 3M n/a, 1Y n/a.
- Trend levels: 52W high ₹37.30, 52W low ₹30.91, off high -4.10%.
- Liquidity: latest turnover is ₹0.57 cr; volume vs 20D is +1.38%.
- Valuation/profitability: PE n/a, PB n/a, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 65.49 cr | 8.72 cr | 6.50 cr | 0.85 |
| 2025-12-31 | 52.00 cr | 6.02 cr | 3.06 cr | 0.40 |
| 2025-09-30 | 44.45 cr | 1.98 cr | -0.56 cr | -0.07 |
| 2025-06-30 | 40.34 cr | 9.82 cr | 8.22 cr | 1.07 |
| 2025-03-31 | 64.81 cr | -0.07 cr | -0.27 cr | -0.03 |
| 2024-12-31 | 49.98 cr | 5.06 cr | n/a | nan |
| 2024-09-30 | n/a | n/a | n/a | 0.34 |
Annual income statement
No recent data available.
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 281.13 cr | 6.19 cr | 56.53 cr | 158.36 cr |
| 2025-09-30 | 260.19 cr | 1.77 cr | 46.61 cr | 147.53 cr |
| 2025-03-31 | 270.04 cr | 4.89 cr | 50.89 cr | 139.98 cr |
| 2024-09-30 | 260.46 cr | 3.39 cr | 51.37 cr | 140.39 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | n/a | n/a | n/a |
| 2025-12-31 | n/a | n/a | n/a |
| 2025-09-30 | n/a | n/a | n/a |
| 2025-06-30 | n/a | n/a | n/a |
| 2025-03-31 | n/a | n/a | n/a |
Shareholding Trend
No recent data available.
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 429,121.06 cr | 40.824543 | +15.06% | +7.26% |
| DIVISLAB | DIVI S LABORATORIES LTD | 174,585.42 cr | 68.707369 | +17.81% | +0.71% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 147,849.87 cr | 68.354079 | +29.94% | +39.35% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 119,204.71 cr | 64.295958 | +23.21% | +21.70% |
| CIPLA | CIPLA LTD | 111,088.72 cr | 29.624450 | +12.91% | -6.65% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 108,331.15 cr | 21.874917 | +20.44% | +16.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 105,181.70 cr | 24.542479 | +13.88% | +1.20% |
| LUPIN | LUPIN LIMITED | 103,385.66 cr | 22.341869 | +29.22% | +15.72% |
Try these prompts
- Analyze AMBALAL SARABHAI ENT L with valuation, momentum and industry peers
- Compare AMBALALSA with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare AMBALALSA with other Healthcare stocks
Data snapshot: 2026-06-03. Not investment advice.